当前位置:
X-MOL 学术
›
J Law Biosci
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The enhanced danger of physicians' off-label prescribing during a public health emergency.
Journal of Law and the Biosciences ( IF 2.5 ) Pub Date : 2020-06-28 , DOI: 10.1093/jlb/lsaa031 Doriane Lambelet Coleman 1 , Philip M Rosoff 2
Journal of Law and the Biosciences ( IF 2.5 ) Pub Date : 2020-06-28 , DOI: 10.1093/jlb/lsaa031 Doriane Lambelet Coleman 1 , Philip M Rosoff 2
Affiliation
On Dec. 26, 2019, a 41-year-old man was admitted to a hospital in Wuhan City, China, with flu-like symptoms including fever, painful cough, fatigue, and generalized achiness that began about a week before he presented for medical care. A novel coronavirus was isolated from his respiratory secretions that was genetically related to the pathogenic coronaviruses that cause SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory distress syndrome).1 This virus is the etiologic agent that causes the disease now known as COVID-19 that is sweeping the globe. It is highly contagious and transmissible with an R0 estimated to be between 1.4 and 3.28.2 To date there is no known effective antiviral treatment or vaccine; current therapy for those most severely affected consists of supportive care. The overall case fatality rate is about 2.3 per cent.3
更新日期:2020-08-28